Healthy Skepticism Library item: 11094
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
[No authors listed].
A step in the right direction.
Nat Rev Drug Discov 2007 Jun; 6:(6):419
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17633785&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Abstract:
Despite the pressing need for new antibiotics in order to avoid a public-health crisis, antibacterial R&D has dwindled seriously in recent years, in part owing to a lack of incentives for companies to make investments in this field. So, the recent passing of an amendment to US legislation that will provide new incentives for antibacterial R&D is to be welcomed.
Keywords:
Publication Types:
Editorial
MeSH Terms:
Anti-Bacterial Agents*
Drug Design*
Drug Industry*
Legislation, Drug*
Vancomycin Resistance
Substances:
Anti-Bacterial Agents
